X-linked cerebral adrenoleukodystrophy
MONDO:0010247A peroxisomal disease characterized by severe inflammatory demyelination in the brain, and often associated with adrenal insufficiency.
Also known as: X-linked cerebral adrenoleukodystrophy, ALD, ALD childhood cerebral form, Addison disease and cerebral sclerosis, Siemerling-Creutzfeldt disease, adrenoleukodystrophy, adrenoleukodystrophy X-linked cerebral form, adrenoleukodystrophy childhood cerebral form
6 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Hope for rare brain disease: new drug trial aims to stall deadly decline
Disease control OngoingThis Phase 3 study tests whether the drug leriglitazone can help adult men with cerebral adrenoleukodystrophy (cALD), a rare and serious brain disease. The main goal is to see if the drug delays death or the need for permanent breathing support compared to a placebo. About 40 men…
Phase: PHASE3 • Sponsor: Minoryx Therapeutics, S.L. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Stem cell infusion aims to buy time for kids with fatal brain disease
Disease control TerminatedThis early-stage trial tests whether a single infusion of donated mesenchymal stem cells is safe for children with cerebral adrenoleukodystrophy (cALD), a rare and life-threatening brain disease. The stem cells are given as a temporary bridge to buy time before a more definitive …
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC